Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
2010
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
January 2009, Allergy and asthma proceedings,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
In Brief: OTC azelastine nasal spray 0.15% (Astepro Allergy) for allergic rhinitis.
October 2022, The Medical letter on drugs and therapeutics,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
[Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis].
December 1998, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Azelastine nasal spray in the management of seasonal allergic rhinitis.
April 1994, Annals of allergy,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.
October 2008, Therapeutics and clinical risk management,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis.
July 1999, The Journal of the American Osteopathic Association,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
January 2001, Arzneimittel-Forschung,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
August 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Azelastine nasal spray for allergic rhinitis.
May 1997, The Medical letter on drugs and therapeutics,
Shailen Shah, and William Berger, and William Lumry, and Craig La Force, and William Wheeler, and Harry Sacks
Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
April 2005, Current medical research and opinion,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name